Invivyd Ownership | Who Owns Invivyd?
Invivyd Ownership Summary
Invivyd is owned by 70.16% institutional investors, 11.28% insiders, and 18.56% retail investors. Point72 asset management is the largest institutional shareholder, holding 16.92% of IVVD shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.84% of its assets in Invivyd shares.
IVVD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Invivyd | 70.16% | 11.28% | 18.56% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Point72 asset management | 20.30M | 16.92% | $22.33M |
| Maverick capital | 18.97M | 15.81% | $20.87M |
| Ra capital management | 17.12M | 14.26% | $18.83M |
| Mithril ii gp lp | 11.24M | 9.37% | $12.37M |
| Driehaus capital management | 10.11M | 8.42% | $11.12M |
| M28 capital management lp | 9.25M | 7.71% | $10.17M |
| Vanguard group | 10.70M | 6.29% | $26.44M |
| Adar1 capital management | 7.37M | 6.14% | $8.11M |
| 683 capital management | 6.30M | 5.25% | $6.93M |
| Soleus capital management | 7.71M | 4.53% | $19.04M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mithril ii gp lp | 11.24M | 19.18% | $12.37M |
| M28 capital management lp | 9.25M | 14.96% | $10.17M |
| Adar1 capital management | 7.37M | 0.76% | $8.11M |
| Soleus capital management | 7.71M | 0.70% | $19.04M |
| 683 capital management | 6.30M | 0.36% | $6.93M |
| Maverick capital | 18.97M | 0.28% | $20.87M |
| Redmile group | 2.29M | 0.24% | $2.51M |
| Ra capital management | 17.12M | 0.23% | $18.83M |
| Ikarian capital | 2.08M | 0.23% | $2.29M |
| Eversept partners, lp | 2.05M | 0.16% | $2.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 20.30M | 0.04% | 20.30M |
| Ra capital management | 17.12M | 0.23% | 17.12M |
| Driehaus capital management | 10.11M | 0.08% | 10.11M |
| Maverick capital | 18.97M | 0.28% | 8.74M |
| Soleus capital management | 7.71M | 0.70% | 7.71M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -8.59M |
| Alphabet | - | - | -4.53M |
| Slate path capital lp | - | - | -3.73M |
| Bain capital life sciences investors | - | - | -1.80M |
| Orbimed advisors | - | - | -933.50K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 20.30M | 0.04% | 20.30M | $22.33M |
| Ra capital management | 17.12M | 0.23% | 17.12M | $18.83M |
| Driehaus capital management | 10.11M | 0.08% | 10.11M | $11.12M |
| Soleus capital management | 7.71M | 0.70% | 7.71M | $19.04M |
| Adar1 capital management | 7.37M | 0.76% | 7.37M | $8.11M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -7.00 |
| True wealth design | -28.00 |
| Capital performance advisors llp | -85.00 |
| Allspring global investments | -157.00 |
| Aspire private capital | -200.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 73 | -9.88% | 119,387,734 | -19.75% | 70 | 0.92% | 44 | -4.35% | 11 | -35.29% |
| Sep 30, 2025 | 54 | -18.18% | 51,837,136 | -14.25% | 43 | 1.70% | 28 | 3.70% | 13 | -50.00% |
| Jun 30, 2025 | 66 | -20.48% | 60,449,578 | -14.15% | 50 | 1.46% | 27 | -27.03% | 26 | -3.70% |
| Mar 31, 2025 | 83 | 7.79% | 70,364,469 | -8.36% | 58 | 1.42% | 39 | 8.33% | 25 | 31.58% |
| Dec 31, 2024 | 77 | - | 76,781,705 | 7.42% | 64 | 1.80% | 36 | 9.09% | 19 | -17.39% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 4.59M | 3.84% | -220.80K |
| Vanguard Total Stock Mkt Idx Inv | 7.39M | 2.62% | - |
| State Street® SPDR® S&P® Biotech ETF | 4.88M | 1.73% | -26.26K |
| Fidelity Growth Company Fund | 1.41M | 1.17% | -21.00K |
| Heptagon Driehaus US Micro Cap Eq C$ Acc | 2.06M | 0.73% | - |
| Fidelity Small Cap Index | 818.96K | 0.68% | -11.62K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.89M | 0.67% | -11.46K |
| Fidelity Growth Company K6 | 503.43K | 0.42% | -38.88K |
| Fidelity Growth Compy Commingled Pl S | 503.40K | 0.42% | -1.93M |
| iShares Russell 2000 ETF | 471.18K | 0.39% | -34.73K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2026 | Allen Robert D. III | Chief Scientific Officer | Sell | $30.60K |
| Feb 17, 2026 | Allen Robert D. III | Chief Scientific Officer | Sell | $28.00K |
| Feb 17, 2026 | Green Julie | Chief Human Resources Officer | Sell | $30.27K |
| Feb 18, 2026 | Green Julie | Chief Human Resources Officer | Sell | $33.08K |
| Feb 17, 2026 | Duke William E. | Chief Financial Officer | Sell | $30.27K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 10 |
| 2025 Q4 | 1 | - |
| 2025 Q3 | - | 10 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
IVVD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools